Reduced expression of BDNF has been associated with Aβ accumulation, tau phosphorylation, neuronal apoptosis and neuroinflammation [16], which further supports the potential of BDNF as a diagnostic biomarker and therapeutic target for AD. Here, BDNF is linked to Alzheimer disease.